Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leung, E. | - |
dc.contributor.author | Gladwish, A. | - |
dc.contributor.author | Sahgal, A. | - |
dc.contributor.author | Lo, S. S. | - |
dc.contributor.author | Kunos, C. A. | - |
dc.contributor.author | Lanciano, R. M. | - |
dc.contributor.author | Mantz, C. A. | - |
dc.contributor.author | Guckenberger, M. | - |
dc.contributor.author | Zagar, T. M. | - |
dc.contributor.author | Mayr, N. A. | - |
dc.contributor.author | Chang, A. R. | - |
dc.contributor.author | Jorcano, S. | - |
dc.contributor.author | Biswas, T. | - |
dc.contributor.author | Pontoriero, A. | - |
dc.contributor.author | Albuquerque, K. V. | - |
dc.date.accessioned | 2021-08-11T08:38:44Z | - |
dc.date.available | 2021-08-11T08:38:44Z | - |
dc.date.issued | 2020-01-30 | - |
dc.identifier.issn | 1748-717X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/3166 | - |
dc.description.abstract | Background Stereotactic Ablative Radiotherapy (SABR) is an effective treatment that improves local control for many tumours. However, the role of SABR in gynecological cancers (GYN) has not been well-established. We hypothesize that there exists considerable variation in GYN-SABR practice and technique. The goal of this study is to describe clinical and technical factors in utilization of GYN-SABR among 11 experienced radiation oncologists. Materials and methods A 63 question survey on GYN-SABR was sent to 11 radiation oncologists (5 countries) who have published original research, conducted trials or have an established program at their institutions. Responses were combined and analyzed at a central institution. Results Most respondents indicated that salvage therapy (non-irradiated or re-irradiated field) for nodal (81%) and primary recurrent disease (91%) could be considered standard options for SABR in the setting of inability to administer brachytherapy. All other indications should be considered on clinical trials. Most would not offer SABR as a boost in primary treatment off-trial without absolute contraindications to brachytherapy. Multi-modality imaging is often (91%) used for planning including PET, CT contrast and MRI. There is a wide variation for OAR tolerances however small bowel is considered the dose-limiting structure for most experts (91%). Fractionation schedules range from 3 to 6 fractions for nodal/primary definitive and boost SABR. Conclusions Although SABR has become increasingly standard in other oncology disease sites, there remains a wide variation in both clinical and technical factors when treating GYN cancers. Nodal and recurrent disease is considered a potential indication for SABR whereas other indications should be offered on clinical trials. This study summarizes SABR practices among GYN radiation oncologists while further studies are needed to establish consensus guidelines for GYN-SABR treatment. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | BioMed Central | - |
dc.title | Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1186/s13014-020-1469-8 | - |
dc.identifier.scopusid | 2-s2.0-85078712352 | - |
dc.identifier.wosid | 000512144000003 | - |
dc.identifier.bibliographicCitation | Radiation Oncology, v.15, no.1 | - |
dc.citation.title | Radiation Oncology | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | BODY RADIATION-THERAPY | - |
dc.subject.keywordPlus | CELL LUNG-CANCER | - |
dc.subject.keywordPlus | CERVICAL-CANCER | - |
dc.subject.keywordPlus | BRACHYTHERAPY | - |
dc.subject.keywordPlus | MODALITY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | Stereotactic | - |
dc.subject.keywordAuthor | Radiation | - |
dc.subject.keywordAuthor | Gynecological | - |
dc.subject.keywordAuthor | Consensus | - |
dc.subject.keywordAuthor | SABR | - |
dc.subject.keywordAuthor | SBRT | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.